Sprucegrove Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Sell |
|
|||||
|
2025
Q1 | $22.6M | Sell |
|
|||||
|
2024
Q4 | $24.8M | Hold |
|
|||||
|
2024
Q3 | $22.6M | Sell |
|
|||||
|
2024
Q2 | $18.5M | Buy |
|
|||||
|
2024
Q1 | $17M | Buy |
|
|||||
|
2023
Q4 | $7.13M | Buy |
|
|||||
|
2023
Q3 | $6.46M | Sell |
|
|||||
|
2023
Q2 | $6.77M | Sell |
|
|||||
|
2023
Q1 | $8.26M | Sell |
|
|||||
|
2022
Q4 | $8.66M | Sell |
|
|||||
|
2022
Q3 | $7.74M | Sell |
|
|||||
|
2022
Q2 | $8.51M | Sell |
|
|||||
|
2022
Q1 | $16.8M | Buy |
|
|||||
|
2021
Q4 | $18M | Sell |
|
|||||
|
2021
Q3 | $19.2M | Sell |
|
|||||
|
2021
Q2 | $19.1M | Sell |
|
|||||
|
2021
Q1 | $18M | Sell |
|
|||||
|
2020
Q4 | $17.6M | Buy |
|
|||||
|
2020
Q3 | $8.86M | Buy |
|